FRI0120 Serum calprotectin is not predictive for successful dose reduction or discontinuation of tnf inhibitors in ra patients with low disease activity

Autor: Thomas Vogl, N. Den Broeder, Fhj van den Hoogen, Rogier M Thurlings, N. van Herwaarden, L. Tweehuysen, A.A. den Broeder

Publikováno v: Poster Presentations.

Background Dose reduction and discontinuation of TNF inhibitors (TNFi) have been shown feasible in a large proportion of RA patients with low disease activity. 1 However, to date, no predictors for successful dose reduction or discontinuation have be

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a87379729f1113e8ded055cfb5a571f5
https://doi.org/10.1136/annrheumdis-2017-eular.1729

FRI0200 Higher acceptance and persistence rates after biosimilar transitioning in patients with a rheumatic disease after employing an enhanced communication strategy

Autor: Fhj van den Hoogen, L. Tweehuysen, A.A. den Broeder, Vjb Huiskes, Bjf van den Bemt

Publikováno v: Poster Presentations.

Background In blinded trials, transitioning from an innovator to a biosimilar has shown to be equivalent to maintenance on innovator biologic treatment in rheumatic diseases. However, data on open label transitioning to a biosimilar are scarce. Recen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::160796d8b033e131e632b2daad0f6858
https://doi.org/10.1136/annrheumdis-2017-eular.2889

Implementation of protocolized tight control and biological dose optimization in daily clinical practice:results of a pilot study

Autor: Lise M Verhoef, Fhj van den Hoogen, R. van Vollenhoven, A.A. den Broeder, P Baudoin, Nienke Lesuis, G A Bruyn, M.E.J.L. Hulscher, L M Nieboer

Publikováno v: Lesuis, N, Verhoef, L M, Nieboer, L M, Bruyn, G A, Baudoin, P, van Vollenhoven, R F, Hulscher, M, van den Hoogen, F & den Broeder, A A 2017, ' Implementation of protocolized tight control and biological dose optimization in daily clinical practice : results of a pilot study ', Scandinavian Journal of Rheumatology, vol. 46, no. 2, pp. 152-155 . https://doi.org/10.1080/03009742.2016.1194457
Scandinavian Journal of Rheumatology, 46(2), 152-155. Informa Healthcare
Scandinavian Journal of Rheumatology, 46, 152-155
Scandinavian Journal of Rheumatology, 46, 2, pp. 152-155
Scandinavian journal of rheumatology, 46(2), 152-155. Informa Healthcare

Item does not contain fulltext OBJECTIVES: To assess the effects of education, guideline development, and individualized treatment advice on rheumatologist adherence to tight control-based treatment and biological dose optimization in rheumatoid arth

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09ab4d1d0d6da7a23c410e186602e03c
https://research.vumc.nl/en/publications/9181297a-d8fb-426f-bcf0-f3fd57ee5c63

Authors' reply

Autor: EAM Mahler, N Cuperus, JJW Bijlsma, TPM Vliet Vlieland, FHJ van den Hoogen, AA den Broeder, CH van den Ende

Publikováno v: Scandinavian journal of rheumatology. 46(2)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2927276eabaee290349940224c6fbaa
https://pubmed.ncbi.nlm.nih.gov/27928927

Impairment in work and activities of daily life in patients with psoriasis: results of the prospective BioCAPTURE registry.

Autor: van Hal TW; Department of Rheumatology, Sint Maartenskliniek, Nijmegen, the Netherlands.; Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., van den Reek JMPA; Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., Wenink MH; Department of Rheumatology, Sint Maartenskliniek, Nijmegen, the Netherlands., Otero ME; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., Ossenkoppele PM; Department of Dermatology, ZiekenhuisGroep Twente, Almelo/Hengelo, the Netherlands., Njoo MD; Department of Dermatology, ZiekenhuisGroep Twente, Almelo/Hengelo, the Netherlands., Oostveen A; Department of Dermatology, Gelre Ziekenhuizen, Apeldoorn, the Netherlands., Peters B; Department of Dermatology, Ziekenhuis Rijnstate, Arnhem, the Netherlands., Tjioe M; Department of Dermatology/DermaTeam, Bravis Ziekenhuis, Bergen op Zoom, the Netherlands., Kop EN; Department of Dermatology, Bernhoven Ziekenhuis, Uden, the Netherlands., Körver JEM; Department of Dermatology, Amphia Ziekenhuis, Breda, the Netherlands., Dodemont SRP; Department of Dermatology, Catharina Ziekenhuis, Eindhoven, the Netherlands., Kleinpenning MM; Department of Dermatology, Canisius-Wilhelmina Ziekenhuis, Nijmegen, the Netherlands., Berends MAM; Department of Dermatology, Slingeland Ziekenhuis, Doetinchem, the Netherlands., Veldkamp WR; Department of Dermatology, Ziekenhuis Gelderse Vallei, Ede, the Netherlands., van Doorn MBA; Department of Dermatology, ErasmusMC, Rotterdam, the Netherlands., Mommers JM; Department of Dermatology, St. Anna Ziekenhuis, Geldrop, the Netherlands., Lindhout RJ; Department of Dermatology, Jeroen Bosch Ziekenhuis, 's Hertogenbosch, the Netherlands., Kuijpers ALA; Department of Dermatology, Maxima Medisch Centrum, Eindhoven, the Netherlands., van Lümig PP; Department of Dermatology, Maastricht UMC+, Maastricht, the Netherlands., de Jonge CEJ; Department of Dermatology, UMC Utrecht, Utrecht, the Netherlands., Tupker RA; Department of Dermatology, Sint Antoniusziekenhuis, Nieuwegein, the Netherlands., Hendricksen J; Department of Dermatology, Streekziekenhuis Koningin Beatrix, Winterswijk, the Netherlands., Keijsers RR; Department of Dermatology, Zuyderland Medisch Centrum, Sittard-Geleen, the Netherlands., van den Hoogen FHJ; Faculty of Medical Sciences, Radboud University, Nijmegen, the Netherlands., Vriezekolk JE; Department of Rheumatology, Sint Maartenskliniek, Nijmegen, the Netherlands.; Department of Research & Innovation, Sint Maartenskliniek, Nijmegen, the Netherlands., de Jong EMGJ; Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Dermatology, ZiekenhuisGroep Twente, Almelo/Hengelo, the Netherlands.

Publikováno v: The Journal of dermatological treatment [J Dermatolog Treat] 2024 Dec; Vol. 35 (1), pp. 2304025. Date of Electronic Publication: 2024 Jan 23.